Federal Liaisons

The Role of the Federal Liaison in the NHSN

Federal Liaisons are scientists or program officers who:

Are affiliated with the NIH or another relevant public health service agency;
Have expertise in drug abuse research, or in a closely related area; and
Have expertise in research with Hispanic populations (applies only to relevant disciplines).

Federal Liaisons are not NHSN members; rather, they provide critical knowledge and guidance to our national network of research scientist and graduate student members. Some of the activities that Federal Liaisons have engaged in include delivering presentations and workshops at the NHSN annual national scientific conference; teaching graduate students and postdoctoral fellows at the Interdisciplinary Research Training Institute; and serving as ad hoc members of the Conference Planning Subcommittee and/or other working subcommittees.

Federal Liaisons

	Flair Lindsey NIDA Project Officer Program Analyst Special Populations Office Office of the Director National Institute on Drug Abuse flindsey@nida.nih.gov
	Judith Arroyo, Ph.D. NIH Minority Health Health Disparities Coordinator National Institute on Alcohol Abuse and Alcoholism jarroyo@mail.nih.gov
	Mario Cerritelli, Ph.D. Chief, Career Development and Outreach Branch National Institute of Arthritis and Musculoskeletal and Skin Diseases cerritem@mail.nih.gov
	Rebecca Clark, Ph.D. Chief, Demographic and Behavioral Sciences Branch Eunice Kennedy Shriver National Institute of Child Health and Human Development rclark@mail.nih.gov
	Kevin P. Conway, Ph.D. Deputy Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse kconway@mail.nih.gov
	Jean Lud Cadet, M.D. Chief, Molecular Neuropsychiatry Branch National Institute on Drug Abuse jcadet@intra.nida.nih.gov
	Marta De Santis, Ph.D. Regulatory Affairs Specialist, Division of Pharmacotherapies and Medical Consequences of Drug Abuse National Institute on Drug Abuse mdesantis@nida.nih.gov
	Joseph Frascella, Ph.D. Director, Division of Clinical Neurosciences & Behavioural Research National Institute on Drug Abuse jfrascel@nida.nih.gov
	Courtney Ferrell Aklin, Ph.D. Program Director National Institute of Neurological Disorders and Stroke courtney.ferrell@nih.gov
	Steve Gust, Ph.D. Director, NIDA International Program Office of Science Policy & Communications National Institute on Drug Abuse ipdirector@nida.nih.gov
	Alfonso Latoni, Ph.D. Deputy Chief, Scientific Review Branch National Institute on Aging alfonso.latoni@nih.gov
	Raúl Mandler, M.D. Senior Medical Officer, Center for Clinical Trials Network National Institute on Drug Abuse mandlerr@mail.nih.gov
	Iván Montoya, M.D., M.P.H. Deputy Director, Division of Pharmacotherapies and Medical Consequesnces of Drug Abuse National Institute on Drug Abuse imontoya@mail.nih.gov
	Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse jnormand@nida.nih.gov
	Ofelia Olivero, Ph.D. Director, Laboratory of Cancer Biology and Genetics National Cancer Institute oliveroo@mail.nih.gov
	LeShawndra Price, Ph.D. Office for Research on Disparities and Global Mental Health lprice@mail.nih.gov
	Carmen Rosa, M.S. Regulatory Affairs Specialist National Institute on Drug Abuse crosa@nida.nih.gov
	Nora Salgado Organizational & Workforce Development Manager National Eye Institute salgadon@nei.nih.gov
	Michael Sesma, Ph.D. Health Scientist Administrator, Division of Developmental Translational Research National Institute of Mental Health msesma@mail.nih.gov
	Hinda Zlotnik, Ph.D. Chief, MBRS Branch Division of Minority Opportunities in Research (MORE) zlotnikh@nigms.nih.gov